MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    The Movement Disorders Society Unified Parkinson Disease Rating Scale Motor Subscore Is Not Associated With Future Parkinson Disease Milestones – an observational study using linked health administrative data

    P. Gros, S. Bronskill, S. Dorrance, X. Wang, M. Chiu, M. Farkouh, C. Marras (Toronto, Canada)

    Objective: To examine the association between time to Parkinson Disease (PD) health administrative data milestones and a one-year change in the Movement Disorders Society –…
  • 2025 International Congress

    Heterogeneity of the First Clinical Manifestations Reported in Patients with Early- and Late-Onset Parkinson’s Disease.

    J. Trejo-Ayala, H. Trujillo-Guerra, J. Sánchez-Garza, D. Ortiz-Zacarías, S. Castillo-Torres, B. Chávez-Luévanos, I. Estrada-Bellmann (Monterrey, Mexico)

    Objective: To compare the onset of clinical manifestations by location and motor or non-motor symptoms in patients with early- and late-onset Parkinson’s Disease (PD) from a movement…
  • 2025 International Congress

    Finding Prodromal Parkinson’s Disease with the Movement Disorder Society’s Prodromal Calculator and Electronic Health Records

    J. Heller, K. Fitzgerald (Baltimore, USA)

    Objective: To explore the ability for electronic health records to identify persons with prodromal Parkinson’s disease in a cohort of those with RBD in the…
  • 2025 International Congress

    Tendencies of Non-Motor Symptoms and Short-Term Clinical Predictors in Patients with Parkinson’s Disease

    R. Nakagawa, M. Shiraishi, N. Takao, H. Matsumoto (Kawasaki City, Kanagawa Prefecture, Japan)

    Objective: This study retrospectively investigated whether the occurrence of non-motor symptoms and the decline in cognitive function in patients with Parkinson’s disease (PD) influence fall…
  • 2025 International Congress

    Investigating the role of NLRP3 Inflammasome as Biomarkers and Therapeutic Targets in Parkinson’s Disease Pathogenesis

    S. Choudhury, N. Kamble, V. Holla, S. M, P. Pal, R. Yadav, P. Alladi (Bangalore, India)

    Objective: To elucidate the role of NLRP3 Inflammasome in PD pathogenesis and its role in differential susceptibility. Background: Inflammasomes play a role in the progression…
  • 2025 International Congress

    The Bjorn Moller Research Repository: A Resource for Movement Disorders Research

    S. Schaffner, A. Kuan, D. Felix, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To build a repository of longitudinally collected biological samples and clinical, demographic, and lifestyle data from individuals with Parkinson’s disease (PD) and other movement…
  • 2025 International Congress

    Utilising Beta Power in Local Networks to Predict Freezing of Gait Events in Parkinson’s Disease

    Y. Tian, E. Matar, S. Lewis (Sydney, Australia)

    Objective: Our study examined brain network changes during the transition to Freezing of Gait (FOG) versus voluntary stopping. Identifying specific neural alterations may help establish…
  • 2025 International Congress

    TMS-EEG Provides Objective Neurophysiological Measures of Motor Fluctuations in Parkinson’s Disease

    M. Roitman, S. Anis, A. Suminski, N. Zifman, H. Fogel, T. Fay-Karmon, S. Hassin-Baer (Ramat Gan, Israel)

    Objective: To assess the correlates TMS evoked potentials (TEPs) measurements changes representing interhemispheric transmission to the change in motor symptoms in 'off' versus 'on' states.…
  • 2025 International Congress

    Combining Pharmaceutical and Digital Treatment Approaches in Parkinson’s Disease Modulates of the Limbic System, Supporting Emotional Regulation and Motivated Behaviors

    N. Saporta, M. Catalogna, T. Tamir, R. Sivan Hoffmann, A. Amedi (Ramat Gan, Israel)

    Objective: Following the combination of standard levodopa treatment with a digital intervention in Parkinson's disease (PD), we assessed the associations between neuroplasticity within the limbic…
  • 2025 International Congress

    Gray Matter Microstructural Integrity in Relation to Frontostriatal and Posterior Cortical Cognitive Performance in Parkinson’s Disease

    Q. Devignes, M. Egan, A. Kayris, S. Peltier, B. Hampstead, L. Hernandez-Garcia (Ann Arbor, USA)

    Objective: Explore relationships of frontostriatal (FS) and posterior cortical (PC) cognitive performance with gray matter (GM) microstructural integrity in Parkinson’s disease (PD). Background: The dual…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley